nkartatx.comHealthcareFounded: 2015Funding to Date: $125MM
Nkarta is a clinical-stage biotechnology company advancing the development of allogeneic natural killer (NK) cell therapies for cancer.
For more details on financing and valuation for Nkarta Therapeutics, register or login.
By registering, you agree to Forge’s Terms of Use. Already registered? Log in
View Enterprise Value for Nkarta Therapeutics.
To read this article and more news on Nkarta Therapeutics, register or login.